MediXSpace is a pioneering company founded in 2020 and headquartered in The Netherlands, operating at the intersection of Digital Health and Health Care. It offers a transformative platform designed to connect doctors and patients in the battle against cancer, emphasizing the importance of collaboration and real-time communication.
The company's slogan, "A cutting-edge platform that brings doctors and patients together in their fight against cancer," encapsulates its mission to foster unity and improve treatment outcomes. MediXSpace's two-fold solution consists of a robust software for healthcare professionals and a user-friendly smartphone app for patients, both aimed at ensuring seamless interaction and daily supervision.
Following a $250.00K Pre Seed Round investment on 25 April 2022 by Newchip Accelerator, MediXSpace appears poised for growth. Its integrative approach and potential to enhance decision-making at all stages of cancer treatment make it an attractive opportunity for investors eyeing the evolving digital health landscape.